Chrysoula Leontiou

Chrysoula Leontiou has a strong background in the field of medicine and pharmaceuticals. chrysoula is currently working at Idorsia Pharmaceuticals Ltd as the Medical Director for Switzerland and Austria, as well as the EUCAN Medical Director. Prior to this, they held positions at Takeda and Shire, where they served as the Global Scientific Director for the Gastroenterology medical franchise and as an Associate Director in medical communications for gastroenterology, rare endocrinology, renal, and neonatology. Chrysoula also has experience as a Freelance Medical Writer and served as an Editorial Board Member for Computational and Structural Biotechnology Journal. chrysoula started their career at ETH Zurich as a Senior Research Associate and Postdoctoral Research Assistant, focusing on protein biochemistry and X-ray crystallography research. chrysoula also worked as a Junior Research Associate at Newcastle University, where they conducted research in oncology and pharmacology, specifically studying drug resistance mechanisms.

Chrysoula Leontiou's education history includes a PhD in Biochemistry, Oncology, and Pharmacology from Newcastle University (1999-2003), an MSc in Medical Molecular Genetics from the University of Aberdeen (1998-1999), and a BSc in Biomedical Sciences from the University of Aberdeen (1994-1998). They also pursued a degree in Health Economics and Policy from The London School of Economics and Political Science (LSE), although the specific dates are not mentioned.